PREMIA, AmoyDx to establish Asia Cancer Clinical Genomic Network

China |  News | 0 Comment | 26 Jun, 2019

Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreement with Amoy Diagnostics and PREMIA Holdings (HK) Ltd. Under the ag...Read more

Target Health, dMed Biopharma join forces for rapid internationalization of clinical trials

China |  News | 0 Comment | 25 Jun, 2019

Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma and device companies capitalize on the rapid internationalization of ...Read more

GENFIT, Terns Pharma announce $228M strategic partnership

China |  News | 0 Comment | 25 Jun, 2019

GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases, has ann...Read more

FDA Grants Orphan Drug Designation to XWL-008 to treat Narcolepsy

China |  News | 0 Comment | 25 Jun, 2019

XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel small molecule therapeutics for the treatment of neurological disorder...Read more

BeiGene, SpringWorks Therapeutics form new entity MapKure

China |  News | 0 Comment | 24 Jun, 2019

BeiGene, Ltd., a China headquartered commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treat...Read more

EMA accepts First "China-Developed" Biosimilar - Henlius HLX02 MAA for Review

China |  News | 0 Comment | 24 Jun, 2019

Henlius, a leading biotech company in China developing both biosimilar and innovative biologics, on 21 June 2019, announced that the European Medicines Agency (EMA) has officially...Read more

Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial

China |  News | 0 Comment | 24 Jun, 2019

Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumours and related diseases, on 24 June 20...Read more

FasT CAR-19 Therapy Shows Positive Impact in Patients with (r/r) B-ALL

China |  News | 0 Comment | 21 Jun, 2019

Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announced preliminary results of a multi-centre pilot study d...Read more

WuXi Biologics to expand integrated biologics conjugation solution center

China |  News | 0 Comment | 21 Jun, 2019

WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, on 21 J...Read more

CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells

China |  News | 0 Comment | 20 Jun, 2019

CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, on 19 June 2019, announced that one of its leading drug candida...Read more

Holmusk signs MoU with Janssen R&D to develop ‘digital mental health strategy’ in China

China |  News | 0 Comment | 19 Jun, 2019

Holmusk has signed a Memorandum of Understanding (MoU) with Janssen (China) Research & Development Center (Janssen), a Division of Johnson & Johnson (China) Investment Ltd., on 19 J...Read more

23Mofang proves PSR association with heredity in Chinese population

China |  News | 0 Comment | 19 Jun, 2019

Chengdu 23Mofang Biotech Company, a startup in Chengdu Tianfu Software Park, has recently published an academic paper on genome-wide association study of photic sneeze reflex in the Ch...Read more

Ping An Good Doctor to develop new healthcare ecosystem

China |  News | 0 Comment | 19 Jun, 2019

Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"), a world leading internet medical and healthcare service provider, has announced a strategic partnership with ...Read more

Varian expands cancer care solutions portfolio with interventional oncology acquisitions

China |  News | 0 Comment | 18 Jun, 2019

Varian has acquired Endocare® Systems, based in Austin, Texas; and Alicon, based in Hangzhou, China.  Endocare is a leading provider of technology for cryoablation and microwa...Read more

Shandong Cancer Hospital joins FlashForward Consortium

China |  News | 0 Comment | 18 Jun, 2019

Varian has announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pacific to join the FlashForward™ Consortium. The Consortium...Read more

AXA Hong Kong, CUHK, Oxford VR launch VR therapy solution

China |  News | 0 Comment | 18 Jun, 2019

AXA Hong Kong, The Chinese University of Hong Kong (CUHK) and Oxford VR (OVR) have jointly launched a first-of-its-kind advanced psychological therapy using virtual reality (VR) t...Read more

Terns Pharmaceuticals initiates Ph1 clinical trial of TERN 101

China |  News | 0 Comment | 17 Jun, 2019

Terns Pharmaceuticals has announced the initiation of Phase 1 clinical trial of TERN-101, a farnesoid X receptor (FXR) agonist, being developed for the treatment of non-alcoholic steat...Read more

China Focus@BIO Conference held in conjunction with 2019 BIO International Convention

China |  News | 0 Comment | 17 Jun, 2019

Ms Kimberly Nearing, Head of Life Sciences at Cedrus Investments (Cedrus), was invited to moderate the first panel of the China Focus@BIO Conference in Philadelphia ...Read more